AKT1 and glioblastoma: UCN-01 abrogated G2/M cell cycle arrest and enhanced the cytotoxic effect of TMZ independently of p53 status [117], whereas inhibition of CHK2 activity was associated with suppression of TMZ efficacy in AKT-overexpressing GBM cells [118].